The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and cognitive-health services. Neurogen Biomarking and ...

Dr. Rany Aburashed, CEO of Neurogen Biomarking, dreams of revolutionizing Alzheimer's detection by making early, accessible testing the new standard of care. Inspired by his clinical, research, and ...

Neurogen Biomarking is expanding its home-based Alzheimer’s testing model through a partnership with Tasso, which will supply its needle-free blood collection devices for use across Neurogen’s ...

Alzheimer’s disease is not just a medical crisis. It is a human one. It affects nearly 7 million Americans today, yet the overwhelming majority are diagnosed only after the disease has taken hold.

BRANFORD, Conn. -- Feb 8, 2008 - Neurogen Corporation today updated the status of its later stage clinical portfolio and announced the future focus of its research efforts. Key elements of the update ...